Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.

We have focused our research and development efforts on diseases for which there are currently few or no treatments available. Editas Medicine works with two distinct CRISPR nucleases: …

Editas Medicine is a pioneering gene editing company focused on developing transformative medicines, translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a …

What is CRISPR gene editing and how can it be used to develop medicines? Learn the gene editing basics and see what medicines Editas Medicine is developing.

Nov 4, 2024 · Access the latest press releases and other information from Editas Medicine, a leading gene editing company dedicated to developing CRISPR medicines for people living …

Get in touch with Editas Medicine, a leading gene editing company dedicated to developing CRISPR-based medicines for people living with serious diseases around the world.

CAMBRIDGE, Mass., June 09, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced positive initial safety and …

EDITAS EDITS THE HBG1 AND HBG2 PROMOTERS USING AsCAS12a ENZYME, DESIGNED TO: • Upregulate HbF robustly Correct anemia with superior red blood cell production and …

Oct 18, 2023 · Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of …

Editas Medicine is building a leading gene editing company that uses CRISPR to develop medicines for people living with serious diseases. Learn more about Editas Medicine, our …